The importance of insulin resistance in polycystic ovary syndrome.
Goodarzi
Mark O
MO
Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA. mgoodarzi@mednet.ucla.edu
Korenman
Stanley G
SG
D001161:Arteriosclerosis / Q000209:etiology; D003920:Diabetes Mellitus / Q000209:etiology; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008687:Metformin / Q000627:therapeutic use; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D018570:Risk Assessment
D007004:Hypoglycemic Agents; D008687:Metformin